George J. Schreiber

Gene expression profiling predicts clinical outcome of breast cancer

Laura van ‘t Veer, Hongyue Dai, Marc J. van de Vijver et al. · Nature · 2002 · 9.5K citations · Full text

Systems Biology, Engineering, Breast Oncology +9

A Gene-Expression Signature as a Predictor of Survival in Breast Cancer

Marc J. van de Vijver, Yudong D. He, Laura van ‘t Veer et al. · New England Journal of Medicine · 2002 · 6.5K citations · Full text

Anti-tumor effects of antibody-alkaline phosphatase conjugates in combination with etoposide phosphate.

Peter D. Senter, Mark G. Saulnier, George J. Schreiber et al. · Proceedings of the National Academy of Sciences · 1988 · 235 citations · Full text

Apoptosis, Immunology, Cell Death +19

Enhancement of the in vitro and in vivo antitumor activities of phosphorylated mitomycin C and etoposide derivatives by monoclonal antibody-alkaline phosphatase conjugates.

Peter D. Senter, George J. Schreiber, David L. Hirschberg et al. · PubMed · 1989 · 96 citations

Apoptosis, Immunology, Alkaline Phosphatase +20

Regressions and cures of melanoma xenografts following treatment with monoclonal antibody beta-lactamase conjugates in combination with anticancer prodrugs.

David E. Kerr, George J. Schreiber, Vivekananda M. Vrudhula et al. · PubMed · 1995 · 58 citations

Anticancer Prodrugs, Tumor Biology, Cephalosporin Doxorubicin +15